Establishing the content validity of the Prescription Opioid Misuse and Abuse Questionnaire (POMAQ) among chronic pain patients

References

• Skolnick P. The opioid epidemic: crisis and solutions. Annu Rev Pharmacol Toxicol. 2018;58:143–159.
   PubMed Web of Science ®Google Scholar
• Meske DS, Lawal OD, Elder H, et al. Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trials. JPR. 2018;11:923–934.
   Web of Science ®Google Scholar
• Vowles KE, McEntee ML, Julnes PS, et al. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156(4):569–576.
   PubMed Web of Science ®Google Scholar
• Lipari RN, Hughes A. How people obtain the prescription pain relievers they misuse. In: The CBHSQ Report. Rockville (MD): Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2017.
   Google Scholar
• National Academies of Sciences and Medicine, editor. Pain management and the opioid epidemic: balancing societal and individual benefits and risks of prescription opioid use. Washington (DC): The National Academies Press; 2017.
   Google Scholar
• Institute of Medicine (IOM). Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington (DC): National Academies Press; 2011.
   Google Scholar
• Smith SM, Dart RC, Katz NP, Nov, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013;154(11):2287–2296.
   PubMed Web of Science ®Google Scholar
• Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6(6):432–442.
   PubMed Web of Science ®Google Scholar
• Belgrade MJ, Schamber CD, Lindgren BR. The DIRE score: predicting outcomes of opioid prescribing for chronic pain. J Pain. 2006;7(9):671–681.
   PubMed Web of Science ®Google Scholar
• Coambs R, Jarry J, Santhiapillai A, et al. The SISAP: a new screening instrument for identifying potential opioid abusers in the management of chronic nonmalignant pain within general medical practice. Pain Res Manage. 1996;1(3):155–162.
   Google Scholar
• Setnik B, Roland CL, Barsdorf AI, et al. The content validation of the Self-Reported Misuse, Abuse and Diversion of Prescription Opioids (SR-MAD) instrument for use in patients with acute or chronic pain. Curr Med Res Opin. 2017;33(6):1067–1076.
   PubMed Web of Science ®Google Scholar
• Butler SF, Fernandez K, Benoit C, et al. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain. 2008;9(4):360–372.
   PubMed Web of Science ®Google Scholar
• Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the current opioid misuse measure. Development and validation of the current opioid misuse measure. Pain. 2007;130(1–2):144–156.
   PubMed Web of Science ®Google Scholar
• Smith SM, Paillard F, McKeown A, et al. Instruments to identify prescription medication misuse, abuse, and related events in clinical trials: an ACTTION systematic review. J Pain. 2015;16(5):389–411.
   PubMed Web of Science ®Google Scholar
• Chou R, Fanciullo GJ, Fine PG, et al. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009;10(2):131–146.
   PubMed Web of Science ®Google Scholar
• Passik SD, Kirsh KL, Casper D. Addiction-related assessment tools and pain management: Instruments for screening, treatment planning, and monitoring compliance. Pain Med. 2008;9(Suppl 2):S145–S166.
   Google Scholar
• Food and Drug Administration, Department of Health and Human Services. Postmarketing Requirements under 505(o) (Study 3033-3). Available from: https://www.fda.gov/media/95546/download.
   Google Scholar
• Coplan PM, Cepeda MS, Petronis KR, et al. Postmarketing studies program to assess the risks and benefits of long-term use of extended-release/long-acting opioids among chronic pain patients. Postgrad Med. 2020;132(1):44–51.
   PubMed Web of Science ®Google Scholar
• Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1-eliciting concepts for a new PRO instrument. Value Health. 2011;14(8):967–977.
   PubMed Web of Science ®Google Scholar
• Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2-assessing respondent understanding. Value Health. 2011;14(8):978–988.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. Fed Regist. 2009;74:65132–65133.
   Google Scholar
• Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singap. 1994;23(2):129–138.
   PubMedGoogle Scholar
• Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.
   Google Scholar
• Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–1288.
   PubMed Web of Science ®Google Scholar